Cost Analysis of the Use of Glatiramer Acetate Compared to Interferon-Â in Patients with Relapsing-Remitting Multiple Sclerosis and Spasticity in Spain
Abstract
Authors
R. Sanchez de la Rosa Bujalance L. Garcia J. Meca Lallana